Schedule 13D ownership disclosure

LAKESHORE BIOPHARMA CO LTD

Ordinary Shares, par value $0.0002 per share · CUSIP: G9845F208

Event date: 2025-08-26

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Huaqin Xue

    Shares: 21,021,332.00 · Class: 51.0%

  • Crystal Peak Holdings Inc.

    Shares: 21,021,332.00 · Class: 51.0%

  • Crystal Peak Investment Inc.Reported CIK 0002078050

    Shares: 21,021,332.00 · Class: 51.0%

  • Dave Liguang Chenn

    Shares: 462,760.00 · Class: 1.1%

  • Oceanpine Investment Fund II LP

    Shares: 410,560.00 · Class: 1.0%

  • Oceanpine Capital Inc.

    Shares: 52,200.00 · Class: 0.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-080942
Form type
SCHEDULE 13D/A
Filer
Crystal Peak Investment Inc.
CIK
CIK 2078050
Filed
Aug 27, 2025
Reporting period
Aug 26, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub